View Older Stories View More Recent Stories
-
Key Energy Services Announces Permanent President and Chief Executive Officer
-
Strauss Group Announces 2019 Results With NIS 8.5 Billion in Revenue, 2.6% Organic Growth Excluding Foreign Currency Effects and a Significant Improvement in the Group's Profits[1]
-
At Home Group Inc. Announces Fourth Quarter Fiscal 2020 Financial Results
-
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
-
Avery Dennison Announces Upcoming Investor Event
-
EU competition chiefs allow suppliers to coordinate to combat coronavirus
-
Global airline capacity may fall up to 35% in 2020 on coronavirus: Moody's
-
Coty (COTY) Reports Operational and Financial Update Amid COVID-19 Outbreak
-
Coty Provides Operational and Financial Update Amid COVID-19 Outbreak
-
Steep capacity cut leaves airlines with overhedged jet fuel headache
-
Kadant Provides Business Update on COVID-19
-
Wolverine World Wide (WWW) is withdrawing its guidance
-
WOLVERINE WORLDWIDE PROVIDES BUSINESS UPDATE RELATED TO COVID-19
-
Devon Energy Provides Hedge Position Update
-
Coronavirus Alert: Price gouging is up
-
WENDEL: 2019 FULL-YEAR RESULTS
-
Virus-spooked Russians hoard trusty staple that is cheap and filling: buckwheat
-
WealthPLAN Partners Turns to Medicare BackOffice® as Resource for Its Financial Advisors
-
Daimler takes further measures in response to the COVID-19 pandemic
-
'Preparing for war': Africans scramble for groceries
-
DUE TO THE ONGOING UNCERTAINTY REGARDING THE COVID-19 PANDEMIC, THE CHILDREN’S PLACE HAS DEFERRED FISCAL 2020 GUIDANCE AND IS CANCELLING ITS CONFERENCE CALL AND WEBCAST REVIEW
-
THE CHILDREN’S PLACE REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS
-
UPDATE: Rosenblatt Upgrades Wix.com (WIX) to Neutral
-
Energy Fuels Announces 2019 Results
-
Micron Solutions (MICR) to Voluntarily Delist and Deregister its Common Stock
-
Micron Solutions, Inc. Announces Intention to Voluntarily Delist and Deregister its Common Stock; Financial Results for Fiscal Year End 2019
-
PRINCE Increases Price of Synthetic High-Purity MnO2 and MnNO3 Product Line
-
Teva Pharma (TEVA) and Celltrion Healthcare Reports U.S. Availability of HERZUMA (trastuzumab-pkrb) for Injection
-
Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for Injection
-
Daimler postpones Annual Shareholders' Meeting
-
Lakeland Industries Adds Capacity to Meet Organic Growth Plans from Traditional Industrial PPE Market and Global Coronavirus Requirements
-
J. Alexander’s Holdings, Inc. Reports Results for Fourth Quarter and Full Year Ended December 29, 2019
-
HeadHunter Group PLC Announces Fourth Quarter and Full-Year 2019 Financial Results
-
HeadHunter Group PLC Announces Fourth Quarter and Full-Year 2019 Financial Results
-
Center Coast Brookfield MLP & Energy Infrastructure Fund Announces Decrease to Monthly Distribution and Upcoming Special Update Call
-
Center Coast Brookfield MLP & Energy Infrastructure Fund Announces Decrease to Monthly Distribution and Upcoming Special Update Call
-
RISE Education Announces Fourth Quarter and Full Year 2019 Unaudited Financial Results
-
Transportation Expert Shines a Light on How Logistics Companies Are Responding to the COVID-19 Crisis
-
Transportation Expert Shines a Light on How Logistics Companies Are Responding to the COVID-19 Crisis
-
U.S. producer prices post biggest drop in five years
-
KP Tissue Releases Fourth Quarter and Full Year 2019 Financial Results
-
Starved of dollars and drowning in debt, Lebanon's economy sinks fast
-
Dorel Reports Q4 and 2019 Year-End Results
-
Dorel Reports Q4 and 2019 Year-End Results
-
IPL Plastics Inc. Reports Fourth Quarter and Fiscal 2019 Financial Results
-
B&G Foods (BGS) Authorizes Extension of Stock Repurchase Program to March
-
Board of Directors of B&G Foods Authorizes Extension of Stock Repurchase Program to March 2021
-
Communications Systems, Inc. Reports 2019 Fourth Quarter and Year-end Financial Results
-
Fivewalls: Millennials Feeling A Perfect Storm is Brewing in the Housing Market
-
U.S. government aims at high insulin prices with plan for $35 copay in Medicare

